InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Joanne Curley, Chief Development Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 21 open-market SEC Form 4 transactions: 0 purchases worth $0 and 21 sales worth $1.2M, reported from May 31, 22 to Aug 21, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 23 | VERAVera Therapeutics, Inc. | SELL | 1.5K | $16.66 | $25K |
| Dec 16, 22 | VERAVera Therapeutics, Inc. | SELL | 1.4K | $20.17 | $27K |
| Dec 13, 22 | VERAVera Therapeutics, Inc. | SELL | 11.7K | $18.28 | $214K |
| Dec 12, 22 | VERAVera Therapeutics, Inc. | SELL | 6.9K | $18.25 | $126K |
| Dec 7, 22 | VERAVera Therapeutics, Inc. | SELL | 494 | $16.47 | $8K |
| Nov 17, 22 | VERAVera Therapeutics, Inc. | SELL | 2.2K | $15.86 | $35K |
| Nov 9, 22 | VERAVera Therapeutics, Inc. | SELL | 494 | $16.54 | $8K |
| Oct 18, 22 | VERAVera Therapeutics, Inc. | SELL | 5.3K | $20.30 | $103K |
| Oct 5, 22 | VERAVera Therapeutics, Inc. | SELL | 988 | $21.64 | $21K |
| Sep 21, 22 | VERAVera Therapeutics, Inc. | SELL | 910 | $22.35 | $19K |
| Sep 20, 22 | VERAVera Therapeutics, Inc. | SELL | 10.1K | $21.00 | $210K |
| Sep 7, 22 | VERAVera Therapeutics, Inc. | SELL | 988 | $18.63 | $18K |
| Aug 22, 22 | VERAVera Therapeutics, Inc. | SELL | 1.0K | $19.65 | $19K |
| Aug 19, 22 | VERAVera Therapeutics, Inc. | SELL | 2.8K | $19.87 | $51K |
| Aug 3, 22 | VERAVera Therapeutics, Inc. | SELL | 988 | $16.81 | $17K |
| Jul 19, 22 | VERAVera Therapeutics, Inc. | SELL | 6.0K | $16.55 | $97K |
| Jul 14, 22 | VERAVera Therapeutics, Inc. | SELL | 6.4K | $15.17 | $96K |
| Jul 7, 22 | VERAVera Therapeutics, Inc. | SELL | 3.5K | $15.08 | $53K |
| Jun 22, 22 | VERAVera Therapeutics, Inc. | SELL | 1.2K | $15.02 | $19K |
| Jun 17, 22 | VERAVera Therapeutics, Inc. | SELL | 3.3K | $15.08 | $50K |
| May 31, 22 | VERAVera Therapeutics, Inc. | SELL | 400 | $15.22 | $6K |